Complexity defines the scope of hepatobiliary and pancreatic surgery, where anatomical challenges and perioperative risks demand meticulous planning. Advances in imaging, surgical navigation, and oncologic criteria have improved resectability in liver and pancreatic tumors previously deemed inoperable. Surgeons are now able to perform anatomical liver segmentectomies, bile duct reconstructions, and minimally invasive pancreatic resections with reduced complications. Enhanced preoperative staging and protocols like ERAS have significantly improved postoperative outcomes. In cases of cholangiocarcinoma or pancreatic cancer, integrating surgical expertise with neoadjuvant therapy and molecular profiling has become central to extending survival. The growing use of robotic assistance and vascular reconstruction further pushes the boundaries of what’s operable. With collaborative input from oncology, hepatology, and transplant teams, the field is moving toward more personalized and curative interventions for diseases that once carried poor prognoses.
Title : Advanced esophageal cancer palliative surgical therapy using isoperistaltic gastric tube
Jose Luis Braga De Aquino, Pontifical Catholic University, Brazil
Title : Evolution of surgical oncology
Nagy Habib, Imperial College London, United Kingdom
Title : Cell therapy for chronic ischemia
Darwin Eton, Vasogenesis Inc, United States
Title : Improving post-operative analgesia regimens after emergency major abdominal surgery
Shifa Bangi, Oxford University Hospitals NHS Trust, United Kingdom
Title : Utility of near-infrared spectroscopy in monitoring renal perfusion following adult kidney transplantation
Sujeet Rai, Dr Ram Manohar Lohia Institute of Medical Sciences, India
Title : Multidisciplinary management of complex skull base pathologies whats in store for the future
Michael Karsy, University of Michigan, United States